← 返回前沿论文

肿瘤特异性但具有免疫抑制作用的 CD39⁺CD8⁺ T 细胞在透明细胞肾细胞癌中发挥双重作用

英文原题:Tumor-specific but immunosuppressive CD39(+)CD8(+) T cells exhibit double-faceted roles in clear cell renal cell carcinoma.

查看英文原题

Tumor-specific but immunosuppressive CD39(+)CD8(+) T cells exhibit double-faceted roles in clear cell renal cell carcinoma.

PubMed 2025/09/16(内容时间) Cell Rep Med Q1 · IF 14(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

CD39 + CD8 + T 细胞被认为是 CD8 + TIL(肿瘤浸润淋巴细胞)(TILs)中的肿瘤抗原特异性细胞。

中文摘要

CD39+ CD8+ T细胞是CD8+TIL(肿瘤浸润淋巴细胞)中的肿瘤抗原特异性细胞。然而,据报道,缺氧肿瘤模型中的CD39+ CD8+ T细胞也具有免疫抑制活性。在此,我们研究透明细胞肾细胞癌(ccRCC)中的CD39+ CD8+ TIL;ccRCC是一种与Von Hippel-Lindau(VHL)突变相关的缺氧肿瘤。单细胞分析证实,CD39+ CD8+细胞是肿瘤特异性CD8+ TIL中的终末耗竭亚群。cAMP和T细胞受体(TCR)信号可直接诱导CD39+ CD8+ T细胞发育。对肾细胞癌(RCC)队列分析发现,CD39+ CD8+ TIL比例与肿瘤突变负荷高及缺氧特征相关。离体功能实验显示,CD39+ CD8+ TIL通过外核苷酸酶活性和腺苷依赖机制发挥免疫抑制作用。ccRCC患者中CD39+ CD8+ TIL富集提示预后较差,但也可预测患者对抗程序性细胞死亡蛋白1(PD-1)治疗有较好应答。CD39+ CD8+ TIL兼具肿瘤抗原特异性和免疫抑制活性这两种特性,解释了其在ccRCC中看似矛盾的预后意义。

展开英文摘要原文

CD39 + CD8 + T cells are known as tumor-antigen-specific cells among CD8 + tumor-infiltrating lymphocytes (TILs). However, CD39 + CD8 + T cells also reportedly exhibit immunosuppressive activity in hypoxic tumor models. Here, we investigate CD39 + CD8 + TILs in clear cell renal cell carcinoma (ccRCC), a Von Hippel-Lindau (VHL) mutation-associated hypoxic tumor. Single-cell analyses confirm that CD39 + CD8 + cells are a terminally exhausted subset of tumor-specific CD8 + TILs. CD39 + CD8 + T cell development is directly induced by cAMP and T cell receptor (TCR) signaling. Analysis of a renal cell carcinoma (RCC) cohort reveals that the proportion of CD39 + CD8 + TILs is associated with a high tumor mutational burden and hypoxic features. Ex vivo functional assays reveal that CD39 + CD8 + TILs exert immunosuppressive activity via ectonucleotidase activity- and adenosine-dependent mechanisms. CD39 + CD8 + TIL enrichment predicts poor prognosis in patients with ccRCC yet also predicts favorable treatment responses to anti-programmed cell death protein 1 (PD-1) therapy. This paradoxical prognostic significance in ccRCC is explained by the dual properties of CD39 + CD8 + TILs: tumor antigen specificity and immunosuppressive activity.

论文信息

作者
Lee YJ、Jeon SH、Yeo JH、Byeon SJ、Jung JH、Nam H、Jeon M、Kim ES
第一作者单位
Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.South Korea
通讯作者单位
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. Electronic address: ecshin@kaist.ac.kr.South Korea
期刊
Cell reports. Medicine2025 Oct 21
原文标识
PubMed 40961944 · DOI 10.1016/j.xcrm.2025.102360